235 related articles for article (PubMed ID: 12954328)
1. Irreversible inhibition of CD13/aminopeptidase N by the antiangiogenic agent curcumin.
Shim JS; Kim JH; Cho HY; Yum YN; Kim SH; Park HJ; Shim BS; Choi SH; Kwon HJ
Chem Biol; 2003 Aug; 10(8):695-704. PubMed ID: 12954328
[TBL] [Abstract][Full Text] [Related]
2. Psammaplin A, a marine natural product, inhibits aminopeptidase N and suppresses angiogenesis in vitro.
Shim JS; Lee HS; Shin J; Kwon HJ
Cancer Lett; 2004 Jan; 203(2):163-9. PubMed ID: 14732224
[TBL] [Abstract][Full Text] [Related]
3. Aminopeptidase-N/CD13 (EC 3.4.11.2) inhibitors: chemistry, biological evaluations, and therapeutic prospects.
Bauvois B; Dauzonne D
Med Res Rev; 2006 Jan; 26(1):88-130. PubMed ID: 16216010
[TBL] [Abstract][Full Text] [Related]
4. Activity screening and structure-activity relationship of the hit compounds targeting APN/CD13.
Wang X; Jing F; Zhu H; Fang H; Zhang J; Xu W
Fundam Clin Pharmacol; 2011 Apr; 25(2):217-28. PubMed ID: 20636366
[TBL] [Abstract][Full Text] [Related]
5. LYP3, a new bestatin derivative for aminopeptidase N inhibition.
Luan Y; Ma C; Sui Z; Wang X; Feng J; Liu N; Jing F; Wang Y; Li M; Fang H; Xu W
Med Chem; 2011 Jan; 7(1):32-6. PubMed ID: 21235517
[TBL] [Abstract][Full Text] [Related]
6. Recent advance in aminopeptidase N (APN/CD13) inhibitor research.
Zhang X; Fang H; Zhang J; Yuan Y; Xu W
Curr Med Chem; 2011; 18(32):5011-21. PubMed ID: 22050749
[TBL] [Abstract][Full Text] [Related]
7. LYP, a novel bestatin derivative, inhibits cell growth and suppresses APN/CD13 activity in human ovarian carcinoma cells more potently than bestatin.
Gao JJ; Gao ZH; Zhao CR; Yuan Y; Cui SX; Zhang XF; Cheng YN; Xu WF; Tang W; Qu XJ
Invest New Drugs; 2011 Aug; 29(4):574-82. PubMed ID: 20111888
[TBL] [Abstract][Full Text] [Related]
8. The effect of different species aminopeptidase N structure on the activity screening of aminopeptidase N inhibitor.
Wang X; Zhang L; Yang K; Zhang C; Zhang J; Fang H; Xu W
Biol Pharm Bull; 2010; 33(10):1658-65. PubMed ID: 20930372
[TBL] [Abstract][Full Text] [Related]
9. Leucine ureido derivatives as aminopeptidase N inhibitors using click chemistry. Part II.
Cao J; Zang J; Kong X; Zhao C; Chen T; Ran Y; Dong H; Xu W; Zhang Y
Bioorg Med Chem; 2019 Mar; 27(6):978-990. PubMed ID: 30737134
[TBL] [Abstract][Full Text] [Related]
10. Aminopeptidase N is a receptor for tumor-homing peptides and a target for inhibiting angiogenesis.
Pasqualini R; Koivunen E; Kain R; Lahdenranta J; Sakamoto M; Stryhn A; Ashmun RA; Shapiro LH; Arap W; Ruoslahti E
Cancer Res; 2000 Feb; 60(3):722-7. PubMed ID: 10676659
[TBL] [Abstract][Full Text] [Related]
11. Novel leucine ureido derivatives as inhibitors of aminopeptidase N (APN).
Ma C; Jin K; Cao J; Zhang L; Li X; Xu W
Bioorg Med Chem; 2013 Apr; 21(7):1621-7. PubMed ID: 23453219
[TBL] [Abstract][Full Text] [Related]
12. Aminopeptidase N (APN)/CD13 inhibitor, Ubenimex, enhances radiation sensitivity in human cervical cancer.
Tsukamoto H; Shibata K; Kajiyama H; Terauchi M; Nawa A; Kikkawa F
BMC Cancer; 2008 Mar; 8():74. PubMed ID: 18366676
[TBL] [Abstract][Full Text] [Related]
13. Aminopeptidase N/CD13 as a potential therapeutic target in malignant pleural mesothelioma.
Otsuki T; Nakashima T; Hamada H; Takayama Y; Akita S; Masuda T; Horimasu Y; Miyamoto S; Iwamoto H; Fujitaka K; Miyata Y; Miyake M; Kohno N; Okada M; Hattori N
Eur Respir J; 2018 May; 51(5):. PubMed ID: 29519924
[TBL] [Abstract][Full Text] [Related]
14. Design of Aminopeptidase N Inhibitors as Anti-cancer Agents.
Amin SA; Adhikari N; Jha T
J Med Chem; 2018 Aug; 61(15):6468-6490. PubMed ID: 29630364
[TBL] [Abstract][Full Text] [Related]
15. Novel leucine ureido derivatives as aminopeptidase N inhibitors using click chemistry.
Cao J; Ma C; Zang J; Gao S; Gao Q; Kong X; Yan Y; Liang X; Ding Q; Zhao C; Wang B; Xu W; Zhang Y
Bioorg Med Chem; 2018 Jul; 26(12):3145-3157. PubMed ID: 29859750
[TBL] [Abstract][Full Text] [Related]
16. A particular expression pattern of CD13 epitope 7H5 in chronic lymphocytic leukaemia--a possible new therapeutic target.
Guenova ML; Michova A; Balatzenko GN; Yosifov DY; Stoyanov N; Taskov H; Berger MR; Konstantinov SM
Hematology; 2012 May; 17(3):132-9. PubMed ID: 22664111
[TBL] [Abstract][Full Text] [Related]
17. Novel leucine ureido derivatives as aminopeptidase N inhibitors. Design, synthesis and activity evaluation.
Ma C; Cao J; Liang X; Huang Y; Wu P; Li Y; Xu W; Zhang Y
Eur J Med Chem; 2016 Jan; 108():21-27. PubMed ID: 26629857
[TBL] [Abstract][Full Text] [Related]
18. Induction of the membrane alanyl aminopeptidase gene and surface expression in human T-cells by mitogenic activation.
Lendeckel U; Wex T; Reinhold D; Kähne T; Frank K; Faust J; Neubert K; Ansorge S
Biochem J; 1996 Nov; 319 ( Pt 3)(Pt 3):817-21. PubMed ID: 8920985
[TBL] [Abstract][Full Text] [Related]
19. Novel small molecule nonpeptide aminopeptidase n inhibitors with a cyclic imide skeleton.
Shimazawa R; Takayama H; Fujimoto Y; Komoda M; Dodo K; Yamasaki R; Shirai R; Koiso Y; Miyata K; Kato F; Kato M; Miyachi H; Hashimoto Y
J Enzyme Inhib; 1999; 14(4):259-75. PubMed ID: 10445048
[TBL] [Abstract][Full Text] [Related]
20. Aminopeptidase N (APN/CD13) as a target for anti-cancer agent design.
Zhang X; Xu W
Curr Med Chem; 2008; 15(27):2850-65. PubMed ID: 18991640
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
